AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Intro
This chapter explores the role of BTK inhibitors in managing mantle cell lymphoma, particularly for older patients and those unable to undergo chemotherapy. Experts share insights from recent trials showcasing improvements in progression-free survival and discuss the potential for these inhibitors as consolidation therapy in younger patients.